Targeted News Service logo

-- Preview Email Newsletter
Journals Biology Newsletter for 2026-03-20 ( 4 items )  
Improving cartilage repair through cell therapy (10)
CAMBRIDGE, Massachusetts, March 19 -- The Massachusetts Institute of Technology posted the following news: * * * Improving cartilage repair through cell therapy * Researchers have developed a new method for monitoring iron flux -the movement and rate at which cells take in, store, use and release iron -in stem cells known as mesenchymal stromal cells (MSCs). The system can provide insights within a minute about a cell's ability to grow cartilage tissue for cartilage repair. The breakthroug more PR

Molecular Biologist Earns GCSU's First Prestigious Cottrell Scholar Award (10)
MILLEDGEVILLE, Georgia, March 20 -- Georgia College issued the following news on March 19, 2026: * * * Molecular biologist earns GCSU's first prestigious Cottrell Scholar Award By Amanda Respess Dr. Arnab Sengupta, assistant professor of cell and molecular biology, has been named a 2026 Cottrell Scholar by the Research Corporation for Science Advancement, placing him among only 24 chemistry, physics and astronomy scholars across the United States and Canada to earn this distinction. Sengu more PR

Research Fellow shares how his practice critiques AI in new in-person and online exhibit (10)
FALMOUTH, England, March 19 -- Falmouth University posted the following news: * * * Research Fellow shares how his practice critiques AI in new in-person and online exhibit * Dr Tom Milnes, a Research Fellow at Falmouth's Centre for Blended Realities (CBR), focuses his practice on exploring the materiality of imagery and technology; engaging with the cultural impact of media through glitches, errors or hidden subcultures. Now, Tom brings his research and practice to Plymouth to curate an exh more PR

UCLA Health: Scientists "Turbocharge" Immune Cells to Attack Prostate Cancer (10)
LOS ANGELES, California, March 20 (TNSjou) -- The UCLA Health issued the following news release: * * * Scientists "turbocharge" immune cells to attack prostate cancer Advance could lead to safer, more effective T cell therapies for prostate cancer and other solid tumors * UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, have engineered a new class of supercharged T cells that are stronger, longer-lasting, and more  more PR